MedPath

葵花药业集团佳木斯鹿灵制药有限公司

Ownership
-
Established
1999-12-14
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

135

NMPA:135

Drug Approvals

颠茄片

Approval Number
国药准字Z23020291
Approval Date
Sep 24, 2020
NMPA

Compound Paracetamol Tablets

Product Name
复方对乙酰氨基酚片
Approval Number
国药准字H23020730
Approval Date
Jul 28, 2020
NMPA

Vitamin C Pills

Product Name
维生素C丸
Approval Number
国药准字H23023583
Approval Date
Jul 28, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H23020814
Approval Date
Jul 28, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H23020815
Approval Date
Jul 28, 2020
NMPA

VitaminB1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H23020809
Approval Date
Jul 28, 2020
NMPA

Metamizole Sodium Tablets

Product Name
愈酚维林片
Approval Number
国药准字H23023615
Approval Date
Jul 28, 2020
NMPA

Pediatric Paracetamol Atificial Cow-bezoar and Chlorphenamine Maleate Tablets

Product Name
小儿氨酚黄那敏片
Approval Number
国药准字H23022832
Approval Date
Jul 28, 2020
NMPA

Mesalazine Enteric Coated Tablets

Product Name
美沙拉嗪肠溶片
Approval Number
国药准字H19980148
Approval Date
Jul 28, 2020
NMPA

Compound Aminopyrine Phenacetin Tablets

Product Name
去痛片
Approval Number
国药准字H23020099
Approval Date
Jul 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.